Table 1.
No acute rejection | One A1 | One A2 | Multiple A1 | Multiple A2 | Multiple AR of mixed types | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N | N | N | N | N | N | |||||||
Median age at transplant (P25, P75) [yr] | 108 | 10.3 (1.4, 15.1) | 50 | 13.7 (7.4, 16.6) | 44 | 12.0 (5.1, 15.4) | 34 | 12.4 (7.6, 15.7) | 73 | 14.2 (12.0, 16.1) | 73 | 13.2 (10.2, 16.2) |
Gender | ||||||||||||
Male | 69 | 64% | 21 | 42% | 24 | 59% | 20 | 59% | 43 | 59% | 49 | 66% |
Female | 39 | 36% | 29 | 58% | 20 | 41% | 14 | 41% | 30 | 41% | 25 | 34% |
Cystic fibrosis | 38 | 35% | 27 | 54% | 21 | 48% | 18 | 53% | 50 | 69% | 54 | 73% |
Type of transplant | ||||||||||||
Single lung | 1 | 1% | 0 | 0% | 0 | 0% | 1 | 3% | 3 | 4% | 1 | 1% |
Double lung | 74 | 79% | 37 | 74% | 33 | 75% | 28 | 82% | 61 | 84% | 62 | 84% |
Heart/lung | 25 | 23% | 10 | 20% | 7 | 16% | 5 | 15% | 3 | 4% | 7 | 10% |
Living donor | 7 | 7% | 3 | 6% | 4 | 9% | 0 | 0% | 6 | 8% | 4 | 5% |
Induction therapy | ||||||||||||
No | 60 | 59% | 25 | 57% | 23 | 58% | 16 | 52% | 42 | 61% | 37 | 56% |
Yes | 41 | 41% | 19 | 43% | 17 | 42% | 15 | 48% | 27 | 39% | 29 | 44% |
Maintenance | ||||||||||||
Cyclosporine | 77 | 71% | 32 | 64% | 32 | 73% | 20 | 59% | 63 | 86% | 52 | 71% |
Tacrolimus | 31 | 29% | 18 | 36% | 12 | 27% | 14 | 41% | 10 | 14% | 21 | 29% |